ENHANZE Drug Delivery Technology Advancing Subcutaneous Drug Delivery using Recombinant Human Hyaluronidase PH20 (Original PDF from Publisher)

ENHANZE Drug Delivery Technology Advancing

The book “ENHANZE® drug delivery technology: Advancing subcutaneous drug delivery using recombinant human hyaluronidase PH20” gives readers a thorough understanding of the history of hyaluronidases and the creation of recombinant human hyaluronidase PH20 (rHuPH20), as well as extensive information on the biology of hyaluronan and hyaluronidases in the SC context. The underlying non-clinical and clinical development methodologies are presented as a foundation for future application to biologics in different disease areas. Current uses of rHuPH20 and authorized biotherapeutics using HuPH20-facilitated SC drug delivery are summarized.